Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Safety of As-Needed Budesonide-Formoterol in Mild Asthma: Data from the Two Phase III SYGMA Studies
J. Mark FitzGerald, Paul M. O’Byrne, Eric D. Bateman, Peter J Barnes, Jinping Zheng, Stefan Ivanov, Rosa Lamarca, Ulrika Larsdotter, Ulrika Emerath, Gerreke Jansen, Margareta Puu, Vijay K. T. Alagappan, Filip Surmont, Helen K. Reddel (2021). Safety of As-Needed Budesonide-Formoterol in Mild Asthma: Data from the Two Phase III SYGMA Studies. , 44(4), DOI: https://doi.org/10.1007/s40264-020-01041-z.
Article209 days agoPositioning As-needed Budesonide–Formoterol for Mild Asthma: Effect of Prestudy Treatment in Pooled Analysis of SYGMA 1 and 2
Eric D. Bateman, Paul M. O’Byrne, J. Mark FitzGerald, Peter J Barnes, Jinping Zheng, Rosa Lamarca, Margareta Puu, Himanshu Parikh, Vijay Alagappan, Helen K. Reddel (2021). Positioning As-needed Budesonide–Formoterol for Mild Asthma: Effect of Prestudy Treatment in Pooled Analysis of SYGMA 1 and 2. , 18(12), DOI: https://doi.org/10.1513/annalsats.202011-1386oc.
Article209 days agoEfficacy of as-needed budesonide/formoterol in mild asthma: pooled analysis of SYGMA 1 and 2
Eric D. Bateman, J. Mark FitzGerald, Helen K. Reddel, Peter J Barnes, Jinping Zheng, Rosa Lamarca, Margareta Puu, Stefan Ivanov, Himanshu Parikh, Vijay K. T. Alagappan, Paul M. O’Byrne (2020). Efficacy of as-needed budesonide/formoterol in mild asthma: pooled analysis of SYGMA 1 and 2. , DOI: https://doi.org/10.1183/13993003.congress-2020.2275.
Article209 days agoEffect of a single day of increased as-needed budesonide–formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 study
Paul M. O’Byrne, J. Mark FitzGerald, Eric D. Bateman, Peter J Barnes, Jinping Zheng, Per Gustafson, Rosa Lamarca, Margareta Puu, Christina Keen, Vijay Alagappan, Helen K. Reddel (2020). Effect of a single day of increased as-needed budesonide–formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 study. , 9(2), DOI: https://doi.org/10.1016/s2213-2600(20)30416-1.
Article209 days agoLate Breaking Abstract - Risk of a severe exacerbation following higher reliever use: post-hoc analysis of SYGMA 1 in mild asthma
Paul M. O’Byrne, J. Mark FitzGerald, Eric D. Bateman, Peter J Barnes, Nanshan Zhong, Christina Keen, Millie Wang, Rosa Lamarca, Margareta Puu, Helen K. Reddel (2018). Late Breaking Abstract - Risk of a severe exacerbation following higher reliever use: post-hoc analysis of SYGMA 1 in mild asthma. , DOI: https://doi.org/10.1183/13993003.congress-2018.oa1680.
Article209 days ago